Richard A. Bryce

Dr. Richard A. Bryce


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in Biophysical Journal
Verified
Journal Article
Closed access
RBRichard A. Bryce
Richard A. Bryce
IHI.H. Hillier
I.H. Hillier
JNJames H Naismith
James H Naismith

1 November 2017 in Cell Chemical Biology
Verified
Journal Article
Open access
ABAlex G. Baldwin
Alex G. Baldwin
JRJack Rivers-Auty
Jack Rivers-Auty
MDMichael J.D. Daniels
Michael J.D. Daniels
CWClaire S. White
Claire S. White
CSCarl H. Schwalbe
Carl H. Schwalbe
DBDavid Brough
David Brough
NLRP3 is a receptor important for host responses to infection, yet is also known to contribute to devastating diseases such as Alzheimer's disease, diabetes, atherosclerosis, and others, making inhibitors for NLRP3 sought after. One of the inhibitors currently in use is 2-aminoethoxy diphenylborinate (2APB). Unfortunately, in addition to inhibiting NLRP3, 2APB also displays non-selective effects on cellular Ca2+ homeostasis. Here, we use 2APB as a chemical scaffold to build a series of inhibitors, the NBC series, which inhibit the NLRP3 inflammasome in vitro and in vivo without affecting Ca2+ homeostasis. The core chemical insight of this work is that the oxazaborine ring is a critical feature of the NBC series, and the main biological insight the use of NBC inhibitors led to was that NLRP3 inflammasome activation was independent of Ca2+. The NBC compounds represent useful tools to dissect NLRP3 function, and may lead to oxazaborine ring-containing therapeutics.

30 October 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KNKaren A. Nolan
Karen A. Nolan
JDJeremy R. Doncaster
Jeremy R. Doncaster
MDMark S. Dunstan
Mark S. Dunstan
KSKatherine A. Scott
Katherine A. Scott
AFA. David Frenkel
A. David Frenkel
RBRichard A. Bryce
Richard A. Bryce

22 August 1998 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
PDF file
RBRichard A. Bryce
Richard A. Bryce
MVMark A. Vincent
Mark A. Vincent
NMNathaniel O. J. Malcolm
Nathaniel O. J. Malcolm
IHIan H. Hillier
Ian H. Hillier
NBNeil A. Burton
Neil A. Burton
A new hybrid quantum mechanical/molecular mechanical model of solvation is developed and used to describe the structure and dynamics of small fluoride/water clusters, using an ab initio wave function to model the ion and a fluctuating charge potential to model the waters. Appropriate parameters for the water–water and fluoride–water interactions are derived, with the fluoride anion being described by density functional theory and a large Gaussian basis. The role of solvent polarization in determining the structure and energetics of F(H2O)4− clusters is investigated, predicting a slightly greater stability of the interior compared to the surface structure, in agreement with ab initio studies. An extended Lagrangian treatment of the polarizable water, in which the water atomic charges fluctuate dynamically, is used to study the dynamics of F(H2O)4− cluster. A simulation using a fixed solvent charge distribution indicates principally interior, solvated states for the cluster. However, a preponderance of trisolvated configurations is observed using the polarizable model at 300 K, which involves only three direct fluoride–water hydrogen bonds. Ab initio calculations confirm this trisolvated species as a thermally accessible state at room temperature, in addition to the tetrasolvated interior and surface structures. Extension of this polarizable water model to fluoride clusters with five and six waters gave less satisfactory agreement with experimental energies and with ab initio geometries. However, our results do suggest that a quantitative model of solvent polarization is fundamental for an accurate understanding of the properties of anionic water clusters.

7 January 2013 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
DMDaniel Mucs
Daniel Mucs
RBRichard A. Bryce
Richard A. Bryce
(2013). The application of quantum mechanics in structure-based drug design. Expert Opinion on Drug Discovery: Vol. 8, No. 3, pp. 263-276. doi: 10.1517/17460441.2013.752812

1 February 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JNJoão Neres
João Neres
MBMark L. Brewer
Mark L. Brewer
LRLaura Ratier
Laura Ratier
HBHoracio Botti
Horacio Botti
ABAlejandro Buschiazzo
Alejandro Buschiazzo
KDKenneth T. Douglas
Kenneth T. Douglas